Monthly Archives: April 2020

The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.25728

Nataf S: An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19. J Med Virol. [Epub ahead of print, Apr. 4, 2020; doi: 10.1002/jmv.25826]. https://www.ncbi.nlm.nih.gov/pubmed/32246784 https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.25826

Abstract: “Chronic low-grade inflammation has been observed in major depression and other major psychiatric disorders and has been implicated in metabolic changes that are commonly associated with these disorders. This raises the possibility that the effects of dysfunctional metabolism may … Continue reading →

The molecular mechanisms underlying the persistence of addiction remain largely unclear. Lepack and colleagues found that, with cocaine exposure, there is an intracellular accumulation of dopamine in neurons of a brain region called the ventral tegmental area. Dopamine associates with … Continue reading →

Abstract: “Psoriasis is a common non-communicable chronic immune-mediated skin disease, affecting approximately 125 million people in the world. Its pathogenesis results from a combination of genetic and environmental factors. The pathogenesis of psoriasis seems to be driven by the interaction … Continue reading →

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1241555/pdf/ehp0111-001065.pdf